Stock listing

Zoetis Inc.

Selected listing: 0M3Q · LSE · USD · GB

Zoetis Inc. (LSE:0M3Q), Health Technology. Latest release Sep 24, 2026: Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results.

0M3Q:LSEUSDGBUpdated September 25, 2026

Ticker: LSE:0M3Q
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: LSE
Currency: USD

About Zoetis Inc.

The company specializes in the development and production of veterinary vaccines and medicines, serving a diverse range of animals, including pets and livestock. Zoetis is committed to improving animal health and well-being through innovative solutions and products.

Latest news from Zoetis Inc.

Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results

September 24, 2026

Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference

September 2, 2026

Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies

August 13, 2026

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

August 6, 2026

Zoetis Announces Second Quarter 2026 Results

August 6, 2026

All Zoetis Inc. news →

Events

Replays

Zoetis Inc. (ZTS) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:30 AM ET
Watch
Zoetis Inc. (ZTS) Q1 2026 Earnings Call
Thu, May 07, 2026 · 08:30 AM ET
Watch
Zoetis Inc. (ZTS) Q4 2025 Earnings Call
Thu, Feb 12, 2026 · 08:30 AM ET
Watch

Research Zoetis Inc.

Zoetis Inc. company profile

View the public company page for Zoetis Inc. on 6ix.

Zoetis Inc. news

Read company news and market updates connected to Zoetis Inc..

Zoetis Inc. investor events

Find investor webinars, events, and replay context for Zoetis Inc..